LD-2 disclosure · 3rd Quarter - Report
THE ALS ASSOCIATION
Client
- Location
- Virginia · United States of America
Registrant
- Description
- Nonprofit 501(c)3
- Location
- Arlington, Virginia, United States of America
Lobbying activities
7 issuesBudget/Appropriations
Further Consolidated Appropriations Act of 2024 (HR 2882) & Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations (S. 2624) --Requested that the House and Senate Appropriations LHHS Subcommittee provide at least $150 million for ALS research at NIH in fiscal year 2024 to attract the next generation of scientists, accelerate the discovery and development of new treatments and increase the number of ALS clinical trials. Requested at least $75 000,000 to implement the expanded access program established by the ACT for ALS Act (P.L. 117-79). Requested at least $15 million to continue CDCs National ALS Registry and Biorepository in fiscal year 2024 to help identify risk factors for ALS to reduce the number of new cases, connect patients with clinical trials, conduct surveillance of incidence and prevalence and biospecimens, and support research of ALS prevention in the military. Requested the House and Senate Appropriations Defense Subcommittee provide at least $80 million for the ALS Research Program in fiscal year 2024 to allow the program to build on a solid foundation of promising preclinical research to increase the number of ALS clinical trials by funding its own early phase trials. Consolidated Appropriations Act of 2024 (HR 4366) . Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations (H.R. 4368) --Requested the House and Senate Appropriations Agriculture Subcommittee provide at least $25 million specifically for ALS research to the FDA Orphan Products Grants Program in fiscal year 2024 to fund P.L. 117-79 the FDA Rare Neurodegenerative Disease Grant Program which is authorized to provide ALS research grants. Continuing Appropriations and Extensions Act, 2025 (H.R.9747) - Provisions related to continuing resolution funding for public health programs, veterans administration, and the Food and Drug Administration. Conversations surrounding Appropriations for Fiscal Year 2025
LobbyistsKATHLEEN SHEEHAN · mrs DENISE DEMICHELE-BAILIN · mr DANIEL NOAH CRAMER
TargetedSENATE · HOUSE OF REPRESENTATIVES
